EMA: Summary report on the EMA workshop on stem cellbased therapies London

The European Medicines Agency (EMA) assembled for the first time European and international experts from academia, regulatory authorities (Europe, Japan, United States and others) and pharmaceutical industry, in a workshop on 10 May 2010, to review opportunities and difficulties in developing stem cell–based therapies and to discuss regulatory challenges.